ANALYSIS: A fully-subscriber funded model is the one we have chosen, and we need to adapt to challenges to protect our IP and grow the business, just as other successful companies do.
ANALYSIS: Like many other medicinal cannabis companies, Greenfern is about to attempt raising more capital but some offers may be better than others.
ANALYSIS: A lack of competitive pressure in the market, combined with difficulty forecasting growth and funding investment, has meant fewer deals were agreed in 2023/24.
ANALYSIS: When it comes to the investment management component of financial services, most people don’t have much of a clue as to whether they have been treated fairly or not.
Release of the fast-track list has prompted a new wave of opposition to the Government’s plan.
ANALYSIS: New Zealand has an opportunity to take the lead on putting regional economic security squarely on the agenda in its discussions with the new US Administration.
ANALYSIS: New Zealand was the second country after Norway to begin raising rates as inflation rose, and it went faster and higher than most other jurisdictions around the world.
ANALYSIS: Heavily redacted details of anti-money laundering compliance failures at SkyCity Auckland have finally been released. They do not show the regulator in a good light.
ANALYSIS: Has this week’s much anticipated debate shown a national conversation on the Treaty Principles Bill might be worthwhile?
ANALYSIS: While many projects on the fast-track list are not controversial there are enough that have created strong political opposition.